NPMMutations in Acute Myelogenous Leukemia
- 20 January 2005
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (3), 291-292
- https://doi.org/10.1056/nejme048337
Abstract
Nucleophosmin (NPM) is a multifunctional phosphoprotein to which both tumor-suppressor and oncogenic functions have been attributed. Chromosomal translocations involving the NPM1 gene occur not infrequently in myeloid and lymphoid cancers. The NPM1 gene rearranges with the retinoic acid receptor α (RARα) gene in acute promyelocytic leukemia and with the anaplastic lymphoma kinase (ALK) gene in a high percentage of anaplastic large-cell lymphomas. Rearrangements with the myeloid leukemia factor 1 (MLF1) gene occur in acute myelogenous leukemia (AML), chronic myelogenous leukemia, and myelodysplasia.13 As a consequence of these translocations, the rearranged NPM1 allele encodes . . .Keywords
This publication has 7 references indexed in Scilit:
- Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal KaryotypeNew England Journal of Medicine, 2005
- Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23Molecular and Cellular Biology, 2004
- Does the ribosome translate cancer?Nature Reviews Cancer, 2003
- Nucleophosmin regulates the stability and transcriptional activity of p53Nature, 2002
- Nucleophosmin/B23 Is a Target of CDK2/Cyclin E in Centrosome DuplicationCell, 2000
- Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activityOncogene, 1997
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994